Document Request
Contact Us
|
Home
Our Technology
Fighting HOB
Our Products
InVision-Plus
InVision-Plus® CLEAR
InVision-Plus CS®
Low Volume Sets/Peds NICU
InVision-Plus® Junior®
InVision-Plus® RED®
InVision-Plus® 5307HPCL
Product Catalog
Resources
Clinical Evidence
Brochures & Product Info
Guidelines
Education
Directions For Use
About RyMed
Our Story
Our Leadership
Contact Us
Our Locations
Employment Opportunities
Ordering Info
Our Technology
Fighting HOB
Our Products
InVision-Plus
InVision-Plus® CLEAR
InVision-Plus CS®
Low Volume Sets/Peds NICU
InVision-Plus® Junior®
InVision-Plus® RED®
InVision-Plus® 5307HPCL
Product Catalog
Resources
Clinical Evidence
Brochures & Product Info
Guidelines
Education
Directions For Use
About RyMed
Our Story
Our Leadership
Contact Us
Our Locations
Employment Opportunities
Ordering Info
Clinical Evidence
InVision-Plus®:
“
Ten Years….One CLABSI Peripheral Approach….20,536 PICC lines: Ownership, Commitment, Technology, and Diligence
.”
APIC 2017 Poster Presentation
(2017) Deborah K. Dix, RN MS; Allison Gonthier, RN, BSN, MHA; The Vascular Access Team of SRMC.
“
Evaluating Intravenous Needleless Connectors: An Evidence Based Report
.”
Johns Hopkins ONS 2013 Poster Presentation
(2013) M. Swisher; M. Olsen; K. Weaver.
“
Seven years of zero central-line-associated bloodstream infections
.”
British Journal of Nursing 21.21
(2013) S. Harnage.
“
Achieving Zero CLABSI: Connector Design Combined with Practice in the Long-Term Acute Care Setting
.”
JAVA Summer 2012
(2012) Debra Lynch, BSN, RN, NE-BC.
“
Protection of Intraluminal Pathway with ZFD Connector Reduces CR-BSI in a Comprehensive Cancer Center
.”
The Journal of the Association for Vascular Access 17.2
(2012): 86-89. B. Caillouet.
“
Choosing the Best Design for IV Needleless Connectors to Prevent HA-BSI
.”
Infection Control Today
(2010): 49:1821-7. W. Jarvis.
“
Catheter Management
.”
Seminars in Oncology Nursing 26.2
(2010): 113-20. D. Macklin.
“
Health Care-Associated Bloodstream Infections Associated with Negative- or Positive-Pressure or Displacement Mechanical Valve Needleless Connectors; CID December (CR-BSI)
.”
Clinical Infectious Diseases
(2009): 49:1821-7. W. Jarvis.
“
Luer Activated Device Priming Volume as a Predictor of Biofilm Formation in an In Vitro Assay
.”
SHEA 2007 poster presentation
(2007) G. Cook; T. Meyer; B. Luchsinger.
“
Achieving Zero CR-BSI: 15 Months Success in a Community Based Medical Center
.”
The Journal of the Association for Vascular Access
(2007): 218-224. S. Harnage.
InVision-Plus CS® with Chlorhexidine + Silver Ion Engineering:
“
Engagement of Frontline Staff and Implementation of a Novel Needleless Connector Results in Dramatic Decrease in Central Line Associated Bloodstream Infections (CLABSI)
.”
APIC 2018 poster presentation
(2018) A. McCombs, MSN, RN, CNML, CIC; H. Cisar, MSN, RN, CNOR.
“
CLABSI Reduction using Novel Techonology and Nursing Best Practice
.”
AVA 2015 poster presentation
(2015) G. Rodriguez, MPH; D. Fraley, RN.
“
IV Connector’s Role in an Initiative to Reduce Bloodstream infections Among Vulnerable Oncology Patients
.”
APIC 2013 poster presentation
(2013) M. Perry; L. Gross.
“
Achieving Zero CLABSI: Connector Design Combined with Practice in the Long Term Acute Care Setting
.”
Poster Presentation
(2011): 1. D. Lynch.